Navigation Links
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
Date:5/2/2013

tigation Reform Act of 1995, including, but not limited to, statements concerning our anticipated product development activities, such as expected clinical trial completion and design and statements regarding the potential benefits and potential development of our product candidates. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including, among others, the risk that our product candidates will not demonstrate the hypothesized or expected benefits, the risk of delays in our expected clinical trials, the risk that new developments in the rapidly evolving cancer therapy landscape require changes in our clinical trial plans or limit the potential benefits of our product candidates and the other factors described in our risk factors set forth in our filings with the Securities and Exchange Commission from time to time, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.

ORCA™, Borealis-1™, Borealis-2™, Spruce™, Rainier™ and Pacific™, are registered trademarks of OncoGenex Pharmaceuticals, Inc.
ABRAXANE® is a registered trademark of Celgene Corporation
JEVTANA® is a registered trademark of sanofi-aventis
Zytiga® is a registered trademark of the Johnson & Johnson Corporation

 


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
2. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
3. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
4. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
5. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
6. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
7. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
8. Avion Pharmaceuticals, LLC., announces further expansion of their Womens Health Sales Team
9. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
10. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
11. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015 Future Market Insights ... "Continuous Glucose Monitoring Systems Market: Global Industry Analysis and ... the global continuous glucose monitoring systems market was valued ... to reach US$ 788.4 Mn by 2020, registering a ... 2020. Global continuous glucose monitoring systems market ...
(Date:7/30/2015)... , July 30, 2015 Vermillion, ... on gynecologic disease, announced today it will ... after the market close on Thursday, August ... call and webcast at 4:30pm Eastern.Conference Call ... at 4:30pm Eastern/1:30pm Pacific  Domestic: ...
(Date:7/30/2015)... HILLS, Calif. , July 30, 2015 /PRNewswire/ ... nanoparticle drug delivery platforms, has received Orphan Drug ... for a second drug product that uses NanoSmart,s ... a formulation of dactinomycin for the treatment of ... cancer. The FDA granted NanoSmart,s Orphan Drug Designation ...
Breaking Medicine Technology:Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2
... provider of the award-winning PatientPad® self-service ... it has earned top honors in the "Emerging Technology ... presented by the Technology Association of Georgia (TAG) and ... this prestigious award for the PatientPad – an innovative ...
... Akron General Medical Center has joined managed technology ... communications capability and efficiency paired with major cost savings. ... with cost reductions both in short and long-term operating ... General,s strategic objectives in the coming years. ...
Cached Medicine Technology:Digital Assent Wins Back-to-Back Spirit of Endeavor Awards, This Year for Top "Emerging Technology Company" 2Digital Assent Wins Back-to-Back Spirit of Endeavor Awards, This Year for Top "Emerging Technology Company" 3Hosted Technology Exchange Welcomes Akron General 2
(Date:7/30/2015)... ... ... Ross A. Clevens, MD, FACS has been reappointed by the ... This is Dr. Clevens’ second appointment by the prestigious school. Over the ... presence and a valuable mentoring program for medical students. , The ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Mesothelioma Applied ... Mesothelioma Patient Registry Act of 2015’. The bill was introduced in Congress yesterday ... (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), and Leonard Lance (R-NJ). The purpose ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Using the latest ... and teach people more effective ways to prevent and manage major depression. , “Suicide ... fast enough, so people fall through the cracks and die needlessly everyday,” says Walker. ...
(Date:7/30/2015)... ... 2015 , ... Boston Web Marketing is proud ... Partners is the platform for search marketing agencies to communicate with the Google ... to run successful search marketing campaigns. Google Partners also affords businesses the opportunity ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Between 2012 and ... the Health News Florida on June 17th. Those untreated heroin use disorders ... to prevent the spread of dirty needles throughout the community. Ultimately Florida’s HIV infection ...
Breaking Medicine News(10 mins):Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3
... (HealthDay News) -- Pregnant women should get a flu shot ... experts say. Pregnancy increases the risk of serious complications ... the March of Dimes. Not only does getting vaccinated ... also confer protection to the baby once it,s born, said ...
... the first time a particlular gene,s link to optimism, self-esteem and ... three critical psychological resources for coping well with stress and ... for a few years, and it is not the gene I ... UCLA and senior author of the new research. "I knew there ...
... , WEDNESDAY, Sept. 14 (HealthDay News) -- Residents of lower ... a new study finds. Sudden cardiac arrest is different ... stops beating and circulation of blood and oxygen to the ... moments. In the study, researchers from the United States ...
... The world,s health professions have launched an easy-to-use, practical ... professionals reduce the risk of noncommunicable diseases (NCDs) ... (1). The WHPA Health Improvement Card consists of a ... and health professionals. , This is part of efforts ...
... HealthDay Reporter , TUESDAY, Sept. 13 (HealthDay News) -- Preventing ... years is the goal of U.S. health officials, who launched ... aim is to raise awareness of the risk factors for ... the country; to improve access to good care; and to ...
... HealthDay Reporter , TUESDAY, Sept. 13 (HealthDay News) ... bicuspid aortic valve live in fear of sudden death, but ... life-threatening complication called aortic dissection. However, these people are ... aneurysm, or bulge in the wall of the aorta, researchers ...
Cached Medicine News:Health News:Pregnant Women Reminded to Get Flu Vaccine 2Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 2Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 3Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 4Health News:Sudden Cardiac Arrest More Common in Poorer Neighborhoods 2Health News:Health professions launch Health Improvement Card to reduce NCD risk 2Health News:U.S. Seeks to Prevent 1 Million Heart Attacks, Strokes 2Health News:U.S. Seeks to Prevent 1 Million Heart Attacks, Strokes 3Health News:Heart Defect Seems to Pose Low Risk of Aorta Tear 2
Used with Temporary Myocardial Heartwires....
Implantable medical grade silicone end cap for insulation and sealing protection of 5 mm or 3.2 mm connectors....
... InSync ICD cardiac resynchronization and ICD device ... (BOL). The unit's RV only sensing provides ... and LV depolarizations, eliminating this cause of ... to LV separation for optimized hemodynamics. Proven ...
... The Guidant Contak Renewal 3 ... ventricular tachyarrhythmia therapy and cardiac ... right ventricular (RV) and left ... Designed to reduce irregular ventricular ...
Medicine Products: